Ticagrelor Removal Study Using CytoSorb® 300 mL Device During CPB in Patients Undergoing Emergent Cardiothoracic Surgery

NCT04625764 · clinicaltrials.gov ↗
NA
Phase
TERMINATED
Status
6
Enrollment
INDUSTRY
Sponsor class

Stopped Due to Corona pandemic, planned ammount of enrolled patient could not be reached, protocol section "Early termination of the study" - criterion "Difficulties in recruiting patients" is fully met-\>recruitment period will not be extended

Conditions

Interventions

Sponsor

CytoSorbents Europe GmbH